Study on the Diagnostic Value of Contrast-Enhanced Ultrasound and Magnetic Resonance Imaging in Prostate Cancer
- PMID: 35979005
- PMCID: PMC9377899
- DOI: 10.1155/2022/7983530
Study on the Diagnostic Value of Contrast-Enhanced Ultrasound and Magnetic Resonance Imaging in Prostate Cancer
Abstract
Objective: The aim is to study the different roles of single and joint application of magnetic resonance imaging (MRI) and contrast-enhanced ultrasound (CEUS) in prostate malignant tumors.
Methods: 72 patients with prostate masses who underwent CEUS and MRI examination in our hospital from October 2021 and March 2022 were enrolled in this research. The differentially diagnostic roles of CEUS, MRI, and CEUS combined MRI for prostate cancer was assessed on basis of pathological findings as the reference standard. The specificity and sensitivity of the joint application for prostate malignant tumors with various prostate-specific antigen (PSA) levels were also evaluated.
Results: The sensitivity of CEUS, MRI, and the joint application for prostate cancer were 72.1%, 74.4%, and 90.7%, respectively. Compared with single application, the sensitivity of CEUS combined with MRI was significantly higher. The specificity of MRI, CEUS, and the combination of the two for prostate cancer were 82.8%, 79.3%, and 89.7%, respectively, and the statistical differences for specificity were not found. The area under ROC curve (AUC) of CEUS combined with MRI in prostate malignant tumor diagnosis was obviously more than that of CEUS and MRI (P < 0.05). CEUS combined with MRI has relative high sensitivity in these patients with different levels of PSA.
Conclusions: Contrast-enhanced ultrasound combined with MRI can significantly improve the sensitivity and specificity of prostate cancer diagnosis so that patients can be better diagnosed in advance.
Copyright © 2022 Xinnian Pang et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures
Similar articles
-
Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.Clin Hemorheol Microcirc. 2018;69(1-2):93-100. doi: 10.3233/CH-189123. Clin Hemorheol Microcirc. 2018. PMID: 29660918
-
The value of contrast-enhanced ultrasound and magnetic resonance imaging in the diagnosis of bladder cancer.J Cancer Res Ther. 2021 Nov;17(5):1179-1185. doi: 10.4103/jcrt.jcrt_1056_21. J Cancer Res Ther. 2021. PMID: 34850765
-
Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.World J Gastroenterol. 2014 Sep 21;20(35):12628-36. doi: 10.3748/wjg.v20.i35.12628. World J Gastroenterol. 2014. PMID: 25253968 Free PMC article.
-
The comparison between contrast-enhanced ultrasound and contrast-enhanced magnetic resonance imaging in diagnosing bladder urothelial carcinoma.Int Urol Nephrol. 2023 May;55(5):1073-1079. doi: 10.1007/s11255-022-03410-2. Epub 2022 Nov 24. Int Urol Nephrol. 2023. PMID: 36422743
-
Multiparametric MRI in detection and staging of prostate cancer.Dan Med J. 2017 Feb;64(2):B5327. Dan Med J. 2017. PMID: 28157066 Review.
Cited by
-
Comparative Assessment of Different Ultrasound Technologies in the Detection of Prostate Cancer: A Systematic Review and Meta-Analysis.Cancers (Basel). 2023 Aug 15;15(16):4105. doi: 10.3390/cancers15164105. Cancers (Basel). 2023. PMID: 37627133 Free PMC article. Review.
-
Diagnostic accuracy of qualitative and quantitative magnetic resonance imaging-guided contrast-enhanced ultrasound (MRI-guided CEUS) for the detection of prostate cancer: a prospective and multicenter study.Radiol Med. 2024 Apr;129(4):585-597. doi: 10.1007/s11547-024-01758-2. Epub 2024 Mar 21. Radiol Med. 2024. PMID: 38512615
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous